GlassScriptPhysician profile
Chester Mays
NPI 1689990624
$19,417.73
in general payments reported to CMS, 2019-2025
19 companies · $3,078 in 2025
The $3,078 reported for 2025 was more than what 89% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,769 · 2020: $924 · 2021: $1,799 · 2022: $3,920 · 2023: $1,424 · 2024: $1,503 · 2025: $3,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,889 · Travel and Lodging: $703 · Long Term Medical Supply Or Device Loan: $326 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,889.10 |
| Travel and Lodging | $703.32 |
| Long Term Medical Supply Or Device Loan | $325.80 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $7,830.51 | 2019-2022 | |
| Allergan, INC. | $2,103.82 | 2019-2022 | |
| Davol INC. | $1,903.96 | 2021-2023 | Phasix Mesh |
| Motiva USA, LLC | $1,624.85 | 2025 | |
| Merz North America, INC. | $1,221.21 | 2020-2025 | Xeomin |
| Rti Surgical, INC | $891.88 | 2022-2025 | |
| Abbvie INC. | $884.79 | 2023-2025 | |
| Tepha INC | $867.56 | 2019 | |
| Revance Therapeutics, INC. | $631.24 | 2024-2025 | Daxxify |
| Integra Lifesciences Corporation | $597.27 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Galderma Laboratories, L.P. | $526.36 | 2019-2025 | |
| Tela Bio, INC. | $130.29 | 2024 | Ovitex 2s |
| Solta Medical, A Division of Bausch Health US, LLC | $85.15 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $36.34 | 2021-2022 | |
| Mentor Worldwide LLC | $21.63 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acacia Pharma INC | $16.60 | 2022 | |
| Eagle Pharmaceuticals, INC. | $16.48 | 2023 | |
| Solventum Corporation | $14.04 | 2025 | Prevena |
| Smith+Nephew, INC. | $13.75 | 2024 | Oasis, Stravix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chester Mays listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.